Essex Bio-Technology Limited

HKEX:1061.HK

2.26 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 1,706.5561,317.7111,637.659978.1111,279.4781,176.458899.59775.663654.01518.3347.047267.255212.716146.282116.688214.071152.67582.7949.19738.90737.58635.67529.7322.392
Cost of Revenue 167.263128.382241.893184.284246.124202.916161.988152.636124.419107.04336.11423.56320.27811.93611.038111.47782.83834.1327.5354.418.00411.4845.9883.82
Gross Profit 1,539.2931,189.3291,395.767793.8271,033.354973.542737.602623.027529.592411.257310.933243.692192.439134.345105.65102.59469.83748.65741.66334.50719.58224.19123.74218.572
Gross Profit Ratio 0.9020.9030.8520.8120.8080.8280.820.8030.810.7930.8960.9120.9050.9180.9050.4790.4570.5880.8470.8870.5210.6780.7990.829
Reseach & Development Expenses 39.14523.50823.5238.5773.40818.1246.4315.65210.7827.0336.5610000000000000
General & Administrative Expenses 216.967155.977153.756111.61281.72468.90940.40547.95951.15842.36825.57426.75519.88511.93215.30216.361.85145.59837.24210.39440.31511.1477.5574.456
Selling & Marketing Expenses 1,011.996758.213835.954476.63632.82649.719515.298410.539352.109271.366212.002168.012133.55389.74869.61863.87300023.312019.47514.85413.556
SG&A 1,189.819914.189989.71588.242714.544718.628555.703458.498403.267313.734237.576194.767153.437101.68184.9280.17361.85145.59837.24233.70640.31530.62122.4118.012
Other Expenses 27.171-6.317-6.824-14.575-10.207-5.2310.9120.0790.1240.0210.03401.1261.4660.834-9.368-5.3510.2630.046-6.811-0.869-1.601-1.038-1.028
Operating Expenses 1,228.963907.872982.886573.667704.337713.397548.906457.549397.287311.922236.077193.77153.437103.14784.9270.80556.49945.8637.28826.89539.44629.0221.37316.984
Operating Income 310.33278.054435.577237.4343.346265.004206.546171.924132.70799.56275.10951.34739.00131.19920.7331.78913.3372.7974.3747.612-19.864-4.832.3691.588
Operating Income Ratio 0.1820.2110.2660.2430.2680.2250.230.2220.2030.1920.2160.1920.1830.2130.1780.1480.0870.0340.0890.196-0.528-0.1350.080.071
Total Other Income Expenses Net 37.326-17.711-41.1213.4558.4198.049-9.5-9.686-2.056-3.808-2.047-1.6961.12600.834-2.573-1.2141.74811.173-0.008-0.298-0.062-0.041-0.085
Income Before Tax 347.656260.343394.457250.855351.765273.054197.046162.238130.65195.75573.06249.65140.12731.19921.56429.21612.1234.54515.5487.605-20.162-4.8922.3281.503
Income Before Tax Ratio 0.2040.1980.2410.2560.2750.2320.2190.2090.20.1850.2110.1860.1890.2130.1850.1360.0790.0550.3160.195-0.536-0.1370.0780.067
Income Tax Expense 70.75534.93148.48931.92949.26341.96229.74725.95425.75620.48218.16510.6566.9254.6144.8112.2571.1210.782-11.1730.0080.298-1.0660.3650.615
Net Income 275.26225.411345.968218.926302.502231.092167.299136.284104.89575.27354.89738.99533.20326.58411.55121.82711.0023.76315.5487.605-20.162-3.7642.0040.974
Net Income Ratio 0.1610.1710.2110.2240.2360.1960.1860.1760.160.1450.1580.1460.1560.1820.0990.1020.0720.0450.3160.195-0.536-0.1060.0670.043
EPS 0.480.390.60.380.520.390.30.240.190.140.0990.070.060.0480.0210.0390.0190.0080.0280.014-0.036-0.0070.0050.003
EPS Diluted 0.470.380.580.370.510.380.290.240.190.130.0990.070.060.0480.0210.0390.0190.0080.0280.014-0.036-0.0070.0050.003
EBITDA 369.839319.967468.548264.999371.142284.651224.151181.932142.916109.58877.73352.6240.20333.16623.9435.51116.6575.4555.7397.612-19.864-4.832.3691.588
EBITDA Ratio 0.2170.2430.2860.2710.290.2420.2490.2350.2190.2110.2240.1970.1890.2270.2050.1660.1090.0660.1170.196-0.528-0.1350.080.071